Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Imidazole → 5-Iodo-2-triisopropylsilanyloxy-benzoic acid methyl ester
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Imidazole | HCID 795 | — |
| 반응물 | Triisopropylsilyl chloride | HCID 139400 | — |
| 반응물 | Methyl 5-Iodosalicylate | HCID 248910 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 5-Iodo-2-triisopropylsilanyloxy-benzoic acid methyl ester | HCID 123371874 | 92.1% |
반응 단계
A solution of methyl 5-iodosalicylate (2.00 g, 7.20 mmol) in DMF (20 mL) was treated with imidazole (1.22 g, 18.0 mmol) then chlorotriisopropylsilane (1.85 mL, 8.60 mmol). The mixture was stirred at RT for 18 h. The mixture was evaporated in vacuo and the residue was partitioned between EtOAc and water. The aqueous layer was then extracted with EtOAc (2×). The combined organic layers were washed with a 10% aqueous citric acid solution, 1N aqueous NaOH solution and brine, dried (Na2SO4), filtered and evaporated in vacuo. The residue was purified by FCC, using 0-10% EtOAc in cyclohexane, to give the title compound as a colorless oil (2.88 g, 92%). LCMS (Method 3): Rt 5.72 min, m/z 435 [MH+].
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09440974B2 |
| 출처 데이터셋 | uspto-grants-2016_09 |
| ORD ID | ord-d2b657b18bee487ca61d7522a786f771 |
| 출처 메모 | uspto-grants-2016_09 |